论文部分内容阅读
摘要目的研究~(18)F-FDG PET与人类表皮生长因子受体2(HER2)阳性乳腺癌及三阴乳腺癌(TNBC)中病理完全缓解(PCR)、雌激素受体阳性/HER2阴性乳腺癌中部分或完全缓解具有最佳关联性的参数。材料与方法本研究获得伦理委员会批准并免除书面同意,连续入组的新辅助化疗乳腺癌病人。对5个PET检查的参数进行研究:标准摄取值(SUV)的最大值(SUV_(max))、最大峰值(SUV_(peak))和平均摄取值(SUV_(mean)),代谢活跃的肿瘤体积和总损伤糖酵解值(TLG)。测
Abstract Objective To investigate the relationship between pathological complete remission (PCR), estrogen receptor positive (HER2) negative breast in ~ (18) F-FDG PET and human epidermal growth factor receptor 2 (HER2) positive breast cancer and triple negative breast cancer (TNBC) The cancer partially or completely relieved the parameters with the best correlation. Materials and Methods The study was approved by Ethics Committee and exempted from written consent, continuous enrolling patients with neoadjuvant chemotherapy breast cancer. The parameters of five PET examinations were studied: the maximum SUV values (SUV max), the maximum peak (SUV peak) and the mean uptake value (SUV mean), the volume of metabolically active tumor And total damage glycolysis (TLG). Measurement